-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
scPharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2021 to Q2 2025.
- scPharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 53.7M shares, a 37.8% increase year-over-year.
- scPharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 44.5M shares, a 15.6% increase from 2023.
- scPharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 38.5M shares, a 35.8% increase from 2022.
- scPharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 28.4M shares, a 3.68% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)